Whole-body 18F-FDG PET/CT scan in a patient with Cervical Cancer taken from the PETWB-REP dataset. The following English report (translated from original Chinese) is taken verbatim from the public dataset and has not been modified or otherwise checked for accuracy (see the end for citation).

Findings

After fasting and intravenous injection of 18F-FDG, a whole-body PET/CT scan was performed.
The whole-body scan showed: The brain morphology and structure were normal, with no abnormal density shadows in the brain parenchyma, and no significant abnormalities in FDG uptake.
No widening of the ventricles, sulci, fissures, or cisterns was observed; the ventricles were symmetrical, and there was no midline shift.
Both eyeballs were symmetrical, with no significant abnormalities.
No thickening of the paranasal sinus mucosa was observed, and the sinus walls were intact.
No thickening of the nasopharyngeal wall was observed, and FDG uptake was normal.
The pharyngeal recesses were symmetrical, the Eustachian tube openings were not narrowed, the infratemporal and pterygopalatine fossae were structurally normal, and the bilateral parapharyngeal spaces were clear with no abnormal FDG uptake.
Both palatine tonsils showed physiological uptake.
No abnormal density shadows were observed in the bilateral parotid and submandibular glands.
The laryngopharynx morphology and structure were normal.
Patchy FDG uptake was observed in the glottic region, with SUVmax = 13.7.
Thyroid gland is normal in shape and size, with slightly uneven density; FDG uptake is normal.
No enlarged lymph nodes were seen in the bilateral deep cervical spaces or submandibular region.
Lung markings are clear bilaterally; multiple solid nodules, approximately 0.3-0.5 cm in diameter, are present bilaterally; FDG uptake is normal.
A few linear lesions are present bilaterally; FDG uptake is normal.
No pleural thickening or pleural effusion/pneumothorax is observed bilaterally.
No significantly enlarged lymph nodes are seen in the bilateral hilar and mediastinal regions.
The cardiac silhouette is normal; cardiac chamber density is lower than myocardial density.
Partial arteriosclerosis is present.
Increased and denser mammary gland tissue is present bilaterally; a soft tissue nodule, approximately 1.3 cm in diameter, is present in the upper inner quadrant of the right breast; FDG metabolism is normal.
The esophagus is not dilated; the esophageal wall is not significantly thickened or lumpy; FDG uptake is normal.
The liver showed no obvious abnormalities in shape and size, with smooth liver margins and no widening of the hepatic fissure.
A cystic lesion, approximately 1.2 cm in diameter, was observed in the right lobe of the liver, with absent FDG uptake.
The main portal vein showed no significant widening, and no dilation of intrahepatic or extrahepatic bile ducts was observed.
The gallbladder showed no abnormalities in shape and size, with no thickening of the gallbladder wall and no abnormalities in local FDG uptake.
The pancreas was normal in shape, with no obvious abnormal density shadows in the parenchyma, no widening of the main pancreatic duct, and no obvious abnormalities in FDG uptake.
The spleen showed no abnormalities in shape, size, density, or FDG uptake.
Two soft tissue density nodules were observed adjacent to the spleen, the larger one approximately 0.6 cm in diameter, with no abnormalities in FDG uptake.
Both kidneys were normal in shape and size, with no obvious abnormal density shadows in the parenchyma, no widening of the renal pelvis, calyces, or ureters, and no obvious abnormalities in FDG uptake.
Bilateral adrenal gland imaging showed no obvious abnormalities.
Stomach distension is poor, with slight thickening of the walls of the cardia and antrum.
FDG uptake is increased, SUVmax=6.1.
Intestinal distension is unsatisfactory, but intestinal uptake is physiological.
The cervix is full, with a visible soft tissue density mass, indistinct borders, measuring approximately 3.7*5.5*3.0cm, involving the upper vagina.
FDG uptake is increased, SUVmax=14.9, and the boundary with the adjacent rectum is indistinct in some areas.
Several cystic lesions are also seen on the cervix, the largest being approximately 1.8cm in length, with absent FDG uptake.
No abnormal density shadows are seen in the rest of the uterus, and FDG metabolism is normal.
Small lymph nodes are visible bilaterally near the iliac vessels, the largest being approximately 0.4cm in short diameter, with no abnormal FDG uptake.
A watery low-density shadow, approximately 4.5cm in length, is seen on the left side of the uterus in the pelvic cavity.
No obvious abnormalities are seen in the bilateral adnexa.
The bladder was poorly filled, but no obvious stones were observed.
The spinal alignment was normal, with some vertebral body margin osteophytes and L4/5 and L5/S1 disc bulges.
A high-density lesion, approximately 0.5 cm in diameter, was observed in the right iliac bone, showing background uptake on FDG.

Impression

1. a. Cervical mass with elevated FDG metabolism, consistent with cervical cancer. b. Nabothian cyst of the cervix. Reactive hyperplasia of small lymph nodes beside the bilateral iliac vessels. Left adnexal cyst or small amount of pelvic effusion. c. Possibly large bony island on the right iliac bone; follow-up is recommended to rule out other possibilities.

2. Chronic inflammatory nodules in both lungs. A few post-inflammatory lesions in both lungs. Anemia changes, partial arteriosclerosis.

3. Bilateral breast hyperplasia, possibly fibroadenoma of the right breast; please confirm with ultrasound examination.

4. Right lobe cyst of the liver. Accessory spleen.

5. Chronic inflammatory changes in the cardia and antrum of the stomach; please confirm with endoscopic follow-up.

6. Degenerative changes in the spine, with L4/5 and L5/S1 intervertebral disc bulges.

7. No obvious abnormalities were found on cranial scintigraphy. Physiological uptake of the glottic area.

This case is from PETWB-REP, a curated dataset of whole-body 18F-FDG PET/CT scans and corresponding radiology reports from 490 patients with a broad spectrum of malignancies. The data were retrospectively collected from patients who underwent clinically indicated whole-body 18F-FDG PET/CT scans at the Shanghai Universal Medical Imaging Diagnostic Center between 2021 and 2024.

License: Creative Commons Attribution 4.0 International (CC BY 4.0)

Citation:
Xue, L., Feng, G., Wenbo, Z., Zhang, Y., Li, L., Wang, S., Peng, L., Peng, S., & Gao, X. (2026). PETWB-REP: A Multi-Cancer Whole-Body FDG PET/CT Dataset with Corresponding Radiology Reports [Data set]. Zenodo. https://doi.org/10.5281/zenodo.18670487